Tecogen (TGEN) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TGEN Hot Sheet
Price: $3.10 --0%
Revenue Growth %: -7.2%
Financial Fact:
Licensing revenue: 29K
Today's EPS Names:
CIX, ARIS, COHR, More
Revenue Growth %: -7.2%
Financial Fact:
Licensing revenue: 29K
Today's EPS Names:
CIX, ARIS, COHR, More
Join SI Premium – FREE
Tecogen (OTC: TGEN) reported Q1 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $5.4 million versus the consensus estimate of $5.74 million.
For earnings history and earnings-related data on Tecogen (TGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- 8x8, Inc. (EGHT) Reports In-Line Q2 EPS
- Viemed Healthcare, Inc. (VMD) Misses Q3 EPS by 2c; updates guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
